This business is about to need another CR based on recent trading.
It's being sold off heavily and becoming a going concern risk.
Failed acquisitions is the main cause (overpaying for junk assets - e.g. MRS). They can't curtail cash burn and make profit from genetics.
Time for a new captain of the ship.
Ann: Appendix 4C Q2FY22 Quarterly Cash Flow Report, page-17
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)